These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25446882)

  • 1. PTEN inhibitors: an evaluation of current compounds.
    Spinelli L; Lindsay YE; Leslie NR
    Adv Biol Regul; 2015 Jan; 57():102-11. PubMed ID: 25446882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting PTEN using small molecule inhibitors.
    Mak LH; Woscholski R
    Methods; 2015 May; 77-78():63-8. PubMed ID: 25747336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisperoxovanadium compounds are potent PTEN inhibitors.
    Schmid AC; Byrne RD; Vilar R; Woscholski R
    FEBS Lett; 2004 May; 566(1-3):35-8. PubMed ID: 15147864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN inhibitors cause a negative inotropic and chronotropic effect in mice.
    Zu L; Shen Z; Wesley J; Cai ZP
    Eur J Pharmacol; 2011 Jan; 650(1):298-302. PubMed ID: 20951693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
    Chen WL; Harris DL; Joyce NC
    Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox Modulation of PTEN Phosphatase Activity by Hydrogen Peroxide and Bisperoxidovanadium Complexes.
    Lee CU; Hahne G; Hanske J; Bange T; Bier D; Rademacher C; Hennig S; Grossmann TN
    Angew Chem Int Ed Engl; 2015 Nov; 54(46):13796-800. PubMed ID: 26418532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VO-OHpic attenuates intervertebral disc degeneration via PTEN/Akt pathway.
    Lin Y; Guo W; Chen KW; Xiao ZM
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2811-2819. PubMed ID: 32271398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SF1670 inhibits apoptosis and inflammation via the PTEN/Akt pathway and thus protects intervertebral disc degeneration.
    Fu HY; Shen L; Gao XS; Cui DX; Cui ZY
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8694-8702. PubMed ID: 32964957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of phosphatase and tensin homolog protects insulin-resistant cells from apoptosis.
    Wang DF; Yang HJ; Gu JQ; Cao YL; Meng X; Wang XL; Lin YC; Gao M
    Mol Med Rep; 2015 Aug; 12(2):2695-700. PubMed ID: 25962562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VAOS, a novel vanadyl complexes of alginate saccharides, inducing apoptosis via activation of AKT-dependent ROS production in NSCLC.
    Zhou L; Yi Y; Yuan Q; Zhang J; Li Y; Wang P; Xu M; Xie S
    Free Radic Biol Med; 2018 Dec; 129():177-185. PubMed ID: 30223019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assaying PTEN catalysis in vitro.
    Spinelli L; Leslie NR
    Methods; 2015 May; 77-78():51-7. PubMed ID: 25461809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatases as small-molecule targets: inhibiting the endogenous inhibitors of kinases.
    Schmid AC; Woscholski R
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):348-9. PubMed ID: 15046606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
    Reed DE; Shokat KM
    Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells.
    Augello G; Puleio R; Emma MR; Cusimano A; Loria GR; McCubrey JA; Montalto G; Cervello M
    Cell Cycle; 2016; 15(4):573-83. PubMed ID: 26794644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model.
    Chen Z; Chen B; Xu WF; Liu RF; Yang J; Yu CX
    Int J Dev Neurosci; 2012 Oct; 30(6):411-9. PubMed ID: 22906543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN Inhibition in Human Disease Therapy.
    Pulido R
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29385737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction.
    Keyes KT; Xu J; Long B; Zhang C; Hu Z; Ye Y
    Am J Physiol Heart Circ Physiol; 2010 Apr; 298(4):H1198-208. PubMed ID: 20097771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Therapeutic Potential of PTEN Modulation: Targeting Strategies from Gene to Protein.
    McLoughlin NM; Mueller C; Grossmann TN
    Cell Chem Biol; 2018 Jan; 25(1):19-29. PubMed ID: 29153852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisperoxovandium (pyridin-2-squaramide) targets both PTEN and ERK1/2 to confer neuroprotection.
    Zhang ZF; Chen J; Han X; Zhang Y; Liao HB; Lei RX; Zhuang Y; Wang ZF; Li Z; Chen JC; Liao WJ; Zhou HB; Liu F; Wan Q
    Br J Pharmacol; 2017 Apr; 174(8):641-656. PubMed ID: 28127755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vanadium pentoxide increased PTEN and decreased SHP1 expression in NK-92MI cells, affecting PI3K-AKT-mTOR and Ras-MAPK pathways.
    Gallardo-Vera F; Tapia-Rodriguez M; Diaz D; Fortoul van der Goes T; Montaño LF; Rendón-Huerta EP
    J Immunotoxicol; 2018 Dec; 15(1):1-11. PubMed ID: 29228829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.